Hansoh Pharmaceutical Group Company Limited
3692
Classifica tra le azioni
#958
Hansoh Pharmaceutical Group Company Limited, an investment holding company,... Hansoh Pharmaceutical Group Company Limited, an investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. The company provides products for therapeutic areas, including anti-infection, central nervous system, oncology, and metabolic and other diseases, as well as autoimmune diseases. Its principal products include Ameile, Hansoh Xinfu, Pulaile, Zefei, Xintai, Xinmei, Gainuo, Tanneng, and Pulaitan; Hengmu, Mailingda, Hengsen, Oulanning, Ailanning, and Ameining; XINYUE; and Saint Luolai, Fulaimei, Ruibote, Fulaidi, Fulairui, Punuoan tablets, etc. It has licence agreements with GlaxoSmithKline Intellectual Property (No.4) Limited to develop, manufacture, and commercialize HS-20089 and HS-20093 for the treatment of patients with extensive-stage small-cell lung cancer (ES-SCLC) with disease progression on or after platinum-based chemotherapy; Biotheus Inc. to develop, produce, and commercialize bispecific antibody-drug conjugate product; and with Merck Sharp & Dohme LLC (MSD) to develop, manufacture, and commercialize HS-10535, an investigational pre-clinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist. The company was founded in 1995 and is headquartered in Shanghai, China. Hansoh Pharmaceutical Group Company Limited is a subsidiary of Stellar Infinity Company Ltd.
Prezzo delle azioni
$4.06
Capitalizzazione di mercato
$24.62B
Variazione (1 giorno)
-7.33%
Variazione (1 anno)
-9.80%
Paese
CN
Scambia Hansoh Pharmaceutical Group Company Limited (3692)
Categoria
Healthcare
Storico del prezzo dell'azione per Hansoh Pharmaceutical Group Company Limited (3692)
Prezzo di chiusura più alto: $4.18 il 2026-10-01
Prezzo di chiusura più basso: $2.44 il 2019-06-01
Prezzo di chiusura più basso: $2.44 il 2019-06-01
Storico del prezzo dell'azione di Hansoh Pharmaceutical Group Company Limited dal 2019 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | -11.29% |
| 2025 | 117.00% |
| 2024 | 23.26% |
| 2023 | 1.33% |
| 2022 | -18.53% |
| 2021 | -49.66% |
| 2020 | 50.59% |
| 2019 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $162.72 | 21.69% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $225.11 | 31.46% |
CH
|
|
| $18.43 | -4.03% |
IN
|
